Skip to main content
. 2022 Dec 26;5(1):e239–e247. doi: 10.1016/j.asmr.2022.11.020

Table 3.

Outcomes

Grooveplasty (n = 18) Trochleoplasty (n = 15) P Value
Mean follow-up (range), mo 50.8 (6.1-94.4) 42.7 (5.6-80.6) .423
Mean arc of motion 131.7 125.5 .134
Recurrent instability 0 (0.0) 5 (33.3) .013
Persistent patellofemoral pain 5 (27.8) 2 (13.3) .413
Patellofemoral chondrosis 8 of 18 (44.4) 3 of 15 (20.0) .266
Chondrosis prior to procedure 6 (75) 2 (66.7)
Complications 3 (16.7) 2 (13.3) >.999
 Wound infection 1 (5.6) 0 (0.0)
 Arthrofibrosis 2 (11.1) 2 (13.3)
Reoperations 4 (22.2) 2 (13.3) .665
 MUA and/or LOA 2 (11.1) 2 (13.3)
 Wound irrigation 1 (5.6) 0 (0.0)
 Trochlear chondroplasty 1 (5.6) 0 (0.0)
 Tibial osteotomy 1 (5.6) 0 (0.0)
PRO, median (IQR)
 Kujala score 82.0 (74.5, 91.0) 69.0 (63.5, 82.0) .059
 Tegner score 6.0 (4.0. 6.5) 4.0 (3.0, 5.0) .052
 Subjective IKDC score 70.1 (58.1, 81.6) 59.2 (55.2, 82.2) .870

NOTE. Data are presented as number (percentage) unless otherwise indicated.

IKDC, International Knee Documentation Committee; IQR, interquartile range; LOA, lysis of adhesions; MUA, manipulation under anesthesia; PRO, patient-reported outcome.

Statistically significant (P < .05).